Best Practice & Research Clinical Rheumatology 28 (2014) 315e330

Contents lists available at ScienceDirect

Best Practice & Research ClinicalRheumatology

journal homepage: www.elsevierheal th.com/berh

9

Assessment and treatment of pain in childrenand adolescents

Chitra Lalloo, BHSc, PhD Candidate a, *,Jennifer N. Stinson, RN-EC, PhD CPNP, Scientist b, 1

a Medical Sciences Graduate Program, Faculty of Health Sciences, McMaster University, 1280 Main StreetWest, HSC-4N35, Canadab Child Health Evaluative Sciences, The Hospital for Sick Children, Lawrence S. Bloomberg, Faculty of Nursing,University of Toronto, The Peter Gilgan Centre for Research and Learning, 686 Bay Street, Room 69715,Toronto, ON M5G 0A4, Canada

Keywords:PainChildrenAdolescentsAssessmentManagementTechnology

* Corresponding author. Tel.: þ1 905 525 9140.E-mail addresses: lallooc@mcmaster.ca (C. Lallo

1 Tel.: þ1 416 813 7654x304514; fax: þ1 416 81

http://dx.doi.org/10.1016/j.berh.2014.05.0031521-6942/© 2014 Elsevier Ltd. All rights reserved

a b s t r a c t

Pain is one of the most common and distressing symptomsexperienced by children and adolescents with juvenile idiopathicarthritis. Pain is known to negatively affect all aspects of health-related quality of life, including physical, emotional, social, androle functioning. The valid and reliable assessment of pain is thefirst critical step to developing an effective plan for pain man-agement. This chapter will address the following key questions:

(1) What is the prevalence and impact of pain in children andadolescents with arthritis?

(2) Why is it important for clinicians to assess the multidi-mensional nature of pain and what are the practical issuesthat should be considered?

(3) What tools are available to help clinicians to assess pain?(4) How can Internet and mobile technologies be used to

improve the assessment of pain?(5) What are the recommended strategies for clinically man-

aging pain, including pharmacological, physical, and psy-chological approaches?

© 2014 Elsevier Ltd. All rights reserved.

o), jennifer.stinson@sickkids.ca (J.N. Stinson).3 8501.

.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330316

Prevalence and impact of pain in children and adolescents with arthritis

How common is pain in juvenile idiopathic arthritis?

Pain is the most common and distressing symptom experienced by children and adolescents withjuvenile idiopathic arthritis (JIA). In a longitudinal study of polyarticular arthritis, N¼ 41 patients (aged8e18 years) completed daily paper diaries over an 8-week period to report daily symptoms andfunction [1]. On average, patients reported the presence of pain on 73% of days, with most patientsreporting pain on more than 60% of days. The average number of painful joints reported on pain dayswas 8.1 ± 12.6. A significant proportion of patients (39%) reported the experience of pain on all diarydays, while a minority (5%) reported no pain over the study period. The average pain intensity was inthe mild range (36.6 ± 24.5 on a 100-point scale), although a sub-group of participants (31%) reportedaverage pain intensity greater than 40 [1]. More recently, a sample of N ¼ 76 patients with JIA (aged9e17 years) completed electronic pain diaries three times per day over a 2-week period [2]. On average,participants reported pain intensity (21.7 ± 20.1), unpleasantness (19.8 ± 19.5), and interference(13.4 ± 15.2) in the mild range on a 100-point scale. Pain was found to interfere most with walkingability, and was also associated with symptoms of stiffness (24.4 ± 23.2) and mild to moderate fatigue(36.6 ± 24.1) [2]. Recently, Kimura and colleagues surveyed North American pediatric rheumatologiststo assess current practices regarding treatment of chronic arthritis pain [3]. The sample includedN ¼ 53 pediatric rheumatologists with an average of 14.0 ± 7.7 years in practice. Overall, 77% of re-spondents agreed that there are pediatric patients who continue to experiencemoderate to severe paindespite adequate treatment with disease-modifying therapy and non-steroidal anti-inflammatorydrugs [3]. These findings are supported by a recent electronic diary study by Bromberg and colleagueswhere a sample of 59 JIA patients aged 8e18 years completed an e-diary three times per day for onemonth [4]. Althoughmost participants were under treatment with a disease-modifying anti-rheumaticdrug (79%) or a biologic agent (47%), patients continued to report pain in 66% of all e-diary entries.Across the entire study period, not one participant was completely pain-free, and 86% of participantsreported at least one high pain level [4]. Several studies have also reported reduced pain thresholds andreduced pain tolerance in patients with JIA, including those with active and quiescent disease [5e7].These lowered pain thresholds and tolerance have been correlated with increased reported pain,suggesting a role for central sensitization and nociceptive pathway plasticity in JIA [8].

How does pain affect health-related quality of life?

Pain is known to negatively impact all aspects of health-related quality of life (HRQL). In a studyinvolving N ¼ 59 patients (aged 8e18 years) and their parents, Sawyer and colleagues found thatchildren and adolescents with JIA experienced significantly more problems with physical, emotional,social, and school functioning than healthy individuals [9]. Furthermore, reports from parents andchildren showed that higher pain levels were associated with more impairment in physical, emotional,and social functioning. In a larger study involving N ¼ 308 adolescents with JIA aged 11, 14, and 17years, Shaw and colleagues found that HRQL scores were less than optimal, particularly related to grossmotor functioning (e.g. kneeling, standing, running) and systemic functioning (e.g. stiffness, jointtenderness, tiring easily, joint swelling) [10]. Lower scores for HRQLwere consistently related to greaterlevels of disability, worse pain, and greater joint involvement. Furthermore, adolescents who weremost likely to rate frustration or depression as one of their biggest problems were those with worsepain [10]. In the survey of pediatric rheumatologists conducted by Kimura and colleagues, 98.1% ofrespondents agreed that there is a strong relationship between pain and perceived quality of life forchildren and adolescents with arthritis [3].

How does pain affect sleep?

Poor sleep and fatigue are other important consequences associated with arthritis pain. In a cross-sectional study involving N ¼ 155 patients (aged 8e16 years) with JIA or juvenile dermatomyositis, all

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 317

participants experienced moderately severe fatigue, and 44% reported sleep disturbances [11].Increased painwas associated with more sleep disturbance, more fatigue, and decreased quality of life.A recent systematic review of sleep in pediatric pain populations identified 9 JIA studies with a total ofN ¼ 310 patients [12]. Overall, findings from behavioural measures and polysomnography demon-strated that children with persistent pain have significantly more sleep disturbances, including lowersleep efficiency, than healthy individuals. Sleep problems were also linked with impaired executivefunctioning. Specifically, more night awakenings predicted poorer rapid visual processing and higherapnea severity scores predicted longer reaction times. The authors of this systematic review concludedthat, “… children with persistent pain commonly suffer from disturbed sleep, which puts them at riskfor poor functional outcomes” (p. 126) [12].

What is the patient experience of living with arthritis pain?

It is important to consider the perspective of patients to better understand the impact of living withJIA. Tong and colleagues recently completed a systematic review of qualitative studies, which included27 studies of N ¼ 542 patients with JIA (aged 6e30 years) [13]. One of the major themes identifiedacross all studies was an aversion to being different. Specifically, patients described the presence ofunrelenting and unpredictable pain as a major disruptor to their sense of normalcy compared withhealthy peers. They also described the experience of disablement due to restrictions on their physical,social, and school activities. These impairments had a negative impact on emotional functioning, suchas feelings of powerlessness and sadness. Another major theme discussed by patients was the stigmaand misunderstanding associated with JIA, including frustration at the ‘invisible’ nature of arthritispain and the unpredictability of symptom flares. The authors of this systematic review concluded, “JIAcan have a debilitating impact on children and adolescents. Patients must contend with unpredictablephases of incapacitating pain, stigmatization, and physical limitations” (p. 1403) [13].

What are the long-term consequences of arthritis pain?

In terms of long-term impact, Packham and Hall followed-up on functional outcomes of adults withlong-standing JIA (average disease duration of 28.3 years± 10.8) [14]. A total ofN¼ 246 adults took partin an interview, clinical examination, and notes review, while N¼ 231 of these individuals completed acomprehensive functional and psychosocial questionnaire. The mean patient age was 35.4 years ± 11.1at the time of the study, and average age at disease onset was 7.1 years ± 4.5. Overall, 24.5% of studyparticipants had moderate clinical inflammation, while 18.8% had severe inflammation. Similarly,54.4% had active arthritis according to laboratory tests (elevated C-reactive protein). A total of 42.9% ofpatients were characterized by severe disability across all disease subtypes. Severe disability was mostcommon among individuals with systemic onset JIA (62.5%) and seronegative polyarticular JIA (50%),while oligoarticular (0%) and enthesitis-related JIA (16.1%) were associated with less functionalimpairment. In terms of emotional impact, a significant proportion of participants had high anxietylevels (31.6%) or had suffered from significant depression in the past (21.1%). Most participantscontinued to experience persistent pain from their arthritis, with 25% reporting pain intensity between26 and 50 (100-point scale) and 32.9% reporting severe pain scores greater than 50. Only 7% of par-ticipants were pain-free at the time of assessment. Themean reported pain score across all participantswas 37. Perceived level of control over pain was ‘poor or very poor’ in 22.8% of participants and‘moderate’ in 45.2% of the sample. The authors of this study concluded, “adults with JIA often havesignificant levels of disability, usually related to severe continuing active disease over a prolongedperiod” (p. 1435) [14].

Section summary

� Pain is the most frequent and distressing symptom associated with JIA.� Intensity is typically reported in the mild to moderate range, although severe pain is experienced ina smaller sub-group during disease flares [1].

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330318

� Many patients continue to experience moderate to severe pain despite adequate treatment withdisease-modifying therapy, biologics, and non-steroidal anti-inflammatory drugs [3,4].

� Pain patterns can be unpredictable, with fluctuations within and between days [1,2,15].� Pain is associated with impairment of physical, emotional, social, and role functioning as well assleep disturbances and fatigue [9e12].

� About half of pediatric patients will continue to have active disease into adulthood, includingsymptoms of pain [14].

Why is it important for clinicians to assess the multidimensional nature of pain and what arethe practical issues that should be considered?

Pain as a multidimensional experience within a biopsychosocial model

Clinical rheumatologists are frequently challenged to assess and manage the pain of children andadolescents with rheumatic disease [16]. In the context of assessment, it is critical to consider pain as amultidimensional experience that is comprised of sensory, affective, and evaluative components [17].The sensory dimension of pain is related to quality (what pain feels like), intensity (how much painhurts), location (spatial distribution of pain), and duration (how long pain lasts). The affectivedimension is related to the emotional impact of pain, such as the extent to which pain is perceived asunpleasant or distressing. The evaluative dimension describes the degree to which pain is perceived tointerfere with physical, psychological, role, and social functioning.

The multidimensional nature of pain is best considered within the context of a biopsychosocialmodel, which encompasses biological, environmental, and cognitive-behavioural mechanisms. Asdescribed by Anthony and Schanberg (2005), the development and maintenance of a child's arthritispain experience is influenced by an interaction of: (1) biological factors such as genetics, disease ac-tivity, abnormal pain processing, and medications; (2) environmental factors such as parent painhistory, parent coping and adjustment, family relationships, as well as school and social relationships;(3) cognitive-behavioural factors such as stress, mood, psychological adjustment, pain coping skills,and self-efficacy [18]. Importantly, several studies have demonstrated that disease activity (e.g.physician global assessment scores) typically accounts for only a small proportion (6.5e28%) of vari-ance in reported pain [19,20]. Other factors that influence pain perception include patient age,developmental status, coping ability, mood, stress levels, as well as family and environmental factors[21]. Thus, an understanding of the many interconnected factors that may contribute to a patient's painexperience can enhance the ability of clinicians to manage pain using multimodal approaches,including pharmacological, physical, and psychological strategies [18]. Importantly, the failure torecognize and manage potential contributing factors to pain, such as poor sleep, anxiety, socialisolation, and inactivity can lead to a cycle of pain and maintenance of symptoms [18].

Pain assessment as a cornerstone of pain management

It is well recognized that pain assessment is the first step in the effective management of pain. Totreat pain effectively, an ongoing assessment of the severity and impact of pain and the patient'sresponse to treatment is essential for disease management. Pain measurement typically refers to aquantification of pain intensity (for example, ‘how much does it hurt?’) [22]. In contrast, painassessment involves a comprehensive characterization of the pain experience by using clinicaljudgement to consider the nature, significance, and context of a patient's pain [22]. The importance ofpain assessment as a cornerstone of disease management has been recognized by a working group ofrepresentatives from the American College of Rheumatology, American Academy of Pediatrics,American Board of Pediatrics, and Association of Rheumatology Health Professionals [23]. This workinggroup established a set of quality measures for the assessment of the process of care in JIA. Specifically,this group recommended that, “pain should be assessed in all patients at the first visit [to a pediatricrheumatologist after a diagnosis has beenmade] and at each subsequent visit that occurs at least 7 daysapart” (p. 13) [23]. The group also emphasized that pain must be assessed using valid and reliable toolsthat are developmentally appropriate for the individual patient.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 319

Sources of pain assessment data

Patient self-report is a key source of data for the assessment of pain in pediatric patients who arecognitively able to describe their pain experience. Research suggests that chronological age is the bestpredictor of whether an individual patient is able to accurately self-report their pain [24]. As describedby von Baeyer (2006), most children aged 5 years and older are able to self-report their current painwhen provided with a developmentally appropriate tool [25]. For children younger than 5 years and/orpatients with cognitive impairment or communication difficulties, an observational pain measureshould be utilized [26]. In all cases, patient self-report of pain should be considered alongsideknowledge of the clinical context, the patient's current state, as well as behavioural observation[27e29]. The same pain scale should also be used for individual patients over time in order to generateconsistent data for longitudinal comparison across the trajectory of disease management.

Practical issues to consider when assessing pain using self-report scales

The issues are discussed in Table 1.

Section summary

� The assessment of pain is a cornerstone of disease management for children and adolescents witharthritis [23].

� Pain is a multidimensional experience that should be considered in the context of a biopsychosocialmodel [18].

� Pain should be assessed frequently and consistently by clinical rheumatologists throughout thedisease management process using valid and reliable measures [23].

� Patient self-report is a key source of pain information and should be considered alongsideknowledge of clinical context, patient narrative, and behavioural observation [25,27e29].

� Most children aged 5 years and older are able to self-report their current painwhen provided with adevelopmentally appropriate tool [25].

� For children younger than 5 years and/or patients with cognitive impairment or communicationdifficulties, an observational pain tool should be used [26].

What tools are available to help clinicians to assess pain?

There are numerous options available to aid the assessment of arthritis pain in children and ado-lescents. The recommended characteristics for a pain scale are provided in Table 2. This section willdescribe traditional paper-based scales that meet these criteria, while the next section will providedetails on more recently developed electronic tools.

Table 1Issues to consider when assessing pediatric pain in clinical practice.

1. Choose an age-appropriate and culturally appropriate pain assessment tool.2. If possible, explain how to use the tool when the patient is not in pain.3. Choose an observational pain tool for patients who are: very young (under 5 years), cognitively impaired, and/or highly

distressed at the time of assessment.4. Use simple vignettes to help the patient gain experience with the pain rating task and establish parameters. For example,

“imagine that you just touched a hot stove. Show me how much hurt you would have”.5. Collect numerous pain ratings for individual patients over time (using the same tool) and keep track of how the scores

correspond with clinical context. For example, how do pain scores change after administering a treatment of knownefficacy versus a painful procedure?

6. Always consider the narrative of patients and parents to provide context for individual pain scores.7. Track pain scores throughout the disease management process, from treatment planning to long-term follow-up.8. Be cognizant of potential discrepancies in the pain scores provided by patients, parents, and clinicians and use discussion

to resolve.

Adapted from Ref. [25]. See also: [28,30e34].

Table 2Recommended features of pain scale for use with children and adolescents.

- Evidence of validity and reliability in target population- Developmentally and culturally appropriate for individual patient- Quickly and easily explainable to patients- Easily and quickly understood by patients who have minimal formal education- Well-liked by patients and clinicians- Easily used with the patient to set goals related to improving pain management and function- Low clinician burden in terms of time to administer, score, and record data- Inexpensive to use- Easy to obtain, reproduce, and distribute to clinicians, patients, and families- Easily disinfected and/or inexpensive enough to discard after use- Available with instructions in various languages

Adapted from Ref. [25]. See also [35,36].

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330320

Self-report measures

Uni-dimensional pain tools (intensity only)There is a high availability of self-report pain scales that assess the magnitude of pain intensity.

Based on the desired features described in Table 2, the recommended tools for use in clinical practiceare:

Verbal rating scales (VRS): use numbers and simple phrases to describe different intensities of pain.Patients are asked to choose the phrase that best represents their pain level, and their score is recordedas the corresponding number. For example, a commonly used VRS is: not at all¼ 0, a little bit¼ 1, quitea lot ¼ 2, and most hurt possible ¼ 3 [37].

Numerical rating scales (NRS): consist of a range of sequential numbers, usually 0e10 or 0e100, whichare presented either verbally or in a graphical format. The scale is anchored by word descriptors suchthat a zero rating corresponds with ‘no pain’ and the highest number corresponds with ‘most painpossible’. The patient is asked to select the one number on the scale that best represents themagnitudeor level of their pain intensity. The NRS can be administered either verbally (patient states their painrating) or on paper (patient circles their pain rating). While the NRS has been extensively validated inadult populations, studies examining validity and reliability in pediatric populations are more recent[38e42]. The NRS requires numeracy skills to complete, and is recommended for children and ado-lescents aged 8 years and older.

Faces pain scales: consist of sequential drawings or photographs of facial expressions that showdifferent degrees of pain [43]. Patients are shown the series of faces and asked to choose the one facethat best represents how they feel inside. Each face has an associated numerical score. Research hasshown that scales with a smiling face for the ‘no pain’ anchor, or a face with tears for the ‘most pain’anchor can influence patient scores. For example, scales with a ‘smiling’ lower anchor may producehigher pain ratings than ‘neutral-faced’ anchors [44]. Thus, it is recommended that the ‘no pain’ anchorshould have a neutral facial expression. Commonly used tools include the Oucher photographic scale[45], the Faces Pain Scale-Revised [46], and the Wong-Baker FACES Pain scale [47]. Faces scales havebeen well validated in children and adolescents aged 5e17 years across several different ethnic andcultural groups [43,48,49]. The Faces Pain Scale-Revised [46] is available at: http://www.webcitation.org/6OsqVjTP6.

Visual analogue scales (VAS): consist of a single vertical or horizontal line with anchors such as ‘no pain’and ‘worst pain imaginable’. The patient is asked to place a mark on the line to show their level of pain.A score is generated bymeasuring the relative position of the patient's mark along the length of the linewith a ruler. The VAS is well validated in children and adolescents and is recommended for patientsaged 8 years and older [49]. One commonly used and well-validated variation of the VAS is the col-oured analogue scale (CAS) [50e52]. The CAS consists of a 100mm long triangle that increases inwidth(from 10 to 30mm) and colour (fromwhite to dark red) and is mounted in plastic with a slidingmarker.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 321

The lower anchor of the scale is labeled ‘no pain’ and the top anchor is labeled ‘most pain’. The back ofthe scale has a ruler ranging from 0 to 10 in 0.25 increments. Patients are asked to slide the markeralong the scale until it reaches the level that depicts their level of pain. Patients do not see the numberthat corresponds to the marker, but this score is recorded by the clinician [50e52].

Graphic rating scales: the most common concrete graphic rating scale is called the Pieces of Hurt tool[53]. It consists of four tokens (e.g. poker chips), which each represent a different amount of pain,ranging from ‘a little hurt’ to ‘the most hurt you could ever have’. The child is asked to choose the tokenthat represents their level of pain. It is recommended for use in pre-school age children. It is easy to useand score, and the instructions have been translated from English into several languages and validatedfor use in Jordanian and Thai children [54,55].

Multidimensional pain toolsThere are a limited number of self-report pain scales that assess multiple dimensions of pain (i.e.

beyond intensity).

Pediatric Pain Questionnaire (PPQ). The design of this tool was modeled after the McGill Pain Ques-tionnaire, which is one of the most commonmultidimensional pain scales for adults [17]. The PPQ usesa 10 cm horizontal VAS anchored with happy and sad faces to assess present pain intensity and worstpain intensity in the past week [56]. Patients are also asked to choose from a list of 46 word descriptorsto express sensory (e.g. cutting), affective (e.g. horrible), and evaluative (e.g. sad) qualities of their pain.Pain location is recorded by asking the patient to colour in painful regions on anterior and posterioraspects of a gender-neutral outline of the body. The PPQ is intended for use in children and adolescentsaged 5e18 years and takes 10e15 min to complete. There are different versions of the PPQ for children,adolescents, and parents. The PPQ-parent form contains items similar to the patient version with theaim of allowing cross-validation of child reports. The PPQ has been translated from English intomultiple languages, including Danish, French, Norwegian, Portuguese, Spanish, and Swedish. Ac-cording to the Cohen criteria, the PPQ has ‘well established’ evidence of validity [56].

Abu-Saad Pediatric Pain Assessment Tool (PPAT). Originally developed for Dutch-speaking children, thePPAT includes a 10 cm VAS to assess present and worst pain intensity [57,58]. It also asks patients toselect from among 32 word descriptors to express sensory (e.g. burning), affective (e.g. fearful), andevaluative (e.g. horrible) dimensions of their pain. The PPAT is intended for use in children and ado-lescents aged 5e16 years, and takes 5e10 min to complete. According to the Cohen criteria, the PPAT is‘approaching well established’ in terms of validity.

Adolescent Pediatric Pain Tool (APPT). This questionnaire was originally developed for children and ad-olescents with post-operative pain and has subsequently been used in patients with acute and chronicdisease-related pain, including arthritis [59,60]. Pain intensity is measured using a 0e100 mm wordgraphic rating scale anchored by the phrases, ‘no pain’, ‘little pain’, ‘medium pain’, ‘large pain’, and‘worst possible pain’. Patients are asked to indicate the location of their pain by colouring painful areason a gender-neutral body outline showing anterior and posterior aspects. A list of 67 word descriptorsis used for patients to express sensory, evaluative, and affective qualities of their pain. The APPT isavailable in English and Spanish. It is intended for use in patients aged 5e17 years and takes 3e6min tocomplete. Jacob and colleagues recently conducted a critical review of the psychometric properties ofthe APPT across multiple studies, and concluded that it has good evidence of construct validity in avariety of painful conditions [61].

Observational (behavioural) measures

As described by von Baeyer and colleagues, observational (behavioural) pain tools should be usedwith children and adolescents who are: (a) too young to understand and use self-report measures (e.g.less than 4 years), (b) too highly distressed to self-report their pain, (c) impaired in their

Fig. 1. Revised FLACC (r-FLACC) behavioural scale. Reprinted with permission. Originally published in Ref. [34]. ©John Wiley andSons.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330322

communicative or cognitive skills, (d) physically restricted by medical treatment (e.g. bandages, me-chanical ventilation, paralyzing drugs), or (e) providing self-report ratings that are considered to beexaggerated, minimized, or unrealistic due to cognitive, emotional, or situational factors according toclinical judgement [26].

Revised FLACC (r-FLACC) behavioural scaleThis scale uses the indicators of facial expression, leg movement, activity, cry, and consolability

(FLACC) to assess pain [33,34]. Each indicator is rated as 0, 1, or 2 based on the observed behaviour inthe patient. The r-FLACC includes pain behaviours that are commonly seen in children with cognitiveimpairments. It is intended for use in children aged 2 months to 8 years, and is simple for clinicians touse, score, and interpret (see Fig. 1).

Non-Communicating Children's Pain Checklist-Revised (NCCPC-R)This checklist was designed to assess pain in children aged 3e18 years who are unable to speak due

to cognitive impairments or disabilities [30,31]. The observer is asked to indicate how often the childhas exhibited specific behaviours over the past 2 h. The checklist is divided into vocal, social, facial,

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 323

activity, body and limbs, physiological, and eating/sleeping categories. Each item is rated as 0 (not atall), 1 (just a little), 2 (fairly often), 3 (very often), or ‘not applicable’. The NCCPC-R has been translatedfromEnglish into French, German, and Swedish. The checklist was designed to be usable by parents andcaregivers without training, as well as other adults who are unfamiliar with a particular child.

Section summary

� There are numerous validated uni-dimensional tools for the self-report of pain intensity. Based onrecent reviews [49,62,63]:

B For children aged 3e4 years, the Pieces of Hurt tool is recommended.

B For children and adolescents aged 8 years and older, a 0e10 numerical rating scale should beconsidered.

B For children aged �5 years who do not understand the NRS, the faces pain scale-revised isrecommended.

� There are a limited number of validated multidimensional self-report tools that assess pain in-tensity, quality, and location:

B For children and adolescents aged 5 years and older, the pediatric pain questionnaire, pediatricpain assessment tool, or adolescent pediatric pain tool can be used.

� For children and adolescents who are unable to self-report pain, a behavioural (observational)measure should be selected:

B For cognitively impaired patients aged 4e21 years, the revised FLACC can be used to assess painin the moment.

B For cognitively impaired patients aged 3e18 years, the non-communicating children's painchecklist-revised can be used with observation of the patient over a 2 h period.

� The same pain assessment tool should be used consistently over time with individual patients inorder to allow for longitudinal score comparison.

Use of Internet and mobile technologies to improve pain assessment

Real time data collection (RTDC) to improve pain assessment

Children and adolescents with arthritis often experience changes in their pain over the course of asingle day, such as exacerbated pain during the morning due to joint stiffness [2,15]. It is important forclinicians to be able to capture these daily fluctuations in arthritis pain in order to evaluate effec-tiveness of their disease management plan, and make adjustments as needed [64].

Themultidimensional pain assessment tools described in the previous section (PPQ, PPAT, APPT) arenot suitable for capturing prospective longitudinal data because they: (a) rely on the patient's ability torecall past pain, and (b) do not capture ‘in the moment’ pain reports in the patient's natural envi-ronment (e.g. home, school). The use of retrospective pain ratings, such as asking patients to recall theirpain from the past week, can introduce significant error and distortion into pain assessment data[65,66]. These recall biases can be influenced by the frequency of painful events within a specified timeperiod, the length of time between painful event and recollection, and the child's psychological state,among other factors [65,67]. Furthermore, the act of reducing pain intensity to a single static numberfails to account for the dynamic, fluctuating nature of arthritis pain over relatively short time periods.

These documented shortcomings of static, retrospective pain ratings can be minimized through theuse of real time data collection (RTDC) methods [68]. This family of techniques is used to “collect dataabout experience as it naturally unfolds in a person's life” (p. S85), and includes ambulatory monitoring,

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330324

experience sampling method and ecological momentary assessment [69]. The use of RTDC minimizesthe risk of recall bias by asking patients to describe their pain ‘right now’ on multiple occasions andalso facilitates the monitoring of within-person changes in pain. By providing multiple snapshots ofpain over a given time period, these longitudinal data can be examined to identify patterns in pain aswell as responsiveness to treatment [65].

While the earliest pediatric RTDC studies used pencil-and-paper pain diaries [70], recent advancesin information and communication technology (e.g. Internet, smartphones) have permitted thedevelopment of electronic methods such as e-diaries. Advantages of this electronic approach overpaper-based techniques include: minimizing errors in data transfer and transcription, ability to capturetime-stamped data, ease of data sharing, increased compliance, and heightened patient satisfaction[65,71,72].

Electronic pain diaries for use in children and adolescents

There are a limited number of multidimensional electronic pain assessment tools for use in childrenand adolescents with arthritis. In 2004, Palermo and colleagues developed the first e-diary to recordpain and functional limitations in children and adolescents with chronic arthritis pain. In a studyinvolving 60 participants aged 8e16 years, this research group compared the e-diary format with atraditional paper diary in terms of patient compliance, accuracy, and acceptability [73]. Results indi-cated that the e-diary method was associated with significantly greater compliance and accuracy inpain reporting. These authors also noted that, “an unparalleled advantage of e-diaries...[is] an objectivedetermination of adherence to the diary protocol through the time- and date-stamped feature, whichcannot be achieved via the p-diary format” (p. 218) [73].

From 2006 to 2008, Stinson and colleagues iteratively developed and evaluated a multidimensionalelectronic pain diary called e-Ouch©. This tool was designed to obtain three daily pain ratings (uponwaking, after school, and before bed). In phase 1, the prototype tool underwent usability testing inadolescents with arthritis [74]. All participants indicated that the tool was easy to learn, use, andunderstand, and was also satisfying to complete. In the next phase, the e-Ouch© was pilot tested interms of acceptability and compliance [75]. Participants rated the tool as highly acceptable and easy touse, and average compliance rates of 71.7% were achieved. Subsequent studies provided evidence ofconstruct validity and feasibility in adolescents with arthritis aged 9e18 years [2].

More recently, Stinson and colleagues developed and evaluated feasibility of the StandardizedUniversal Pain Evaluation for Rheumatology providers (SUPER-KIDZ) using a two-phased approach[76]. In phase 1, consensus was established across rheumatologists and pediatric pain expertsregarding the most important pain domains that should be assessed in routine clinical rheuma-tology practice. This iterative consensus process was used to generate self- and proxy-report painmeasures. The final SUPER-KIDZ measure consisted of four domains: (i) pain intensity and location,(ii) fatigue, (iii) pain interference/evaluative, and (iv) affective/emotional dimension. There is a self-report version for children (aged 4e7 years) and youth (aged 8e18 years), as well as a proxy-reportversion for the parents of children aged 4e7 years. In the next phase, a prospective study of 100children and adolescents aged 4e18 years was completed to determine the feasibility and accept-ability of three mediums of tool administration (paper, computer, and iPod Touch). Children, par-ents, and healthcare providers found the tool very acceptable and easy to use. Most children (65%)preferred the computer-based version, while youth reported no preference between differentmedia. The majority of physicians (60%) indicated that they would recommend the computersummary over the paper questionnaire to a colleague [76]. Validity trials are currently underway.Once validated, the SUPER-KIDZ tools will be included in CARRAnet, an online battery of measuresthat are used with all pediatric rheumatology patients during routine clinic visits across NorthAmerica.

Pain-QuILT™ (previously called the iconic pain assessment tool) is a web- andmobile-based tool forthe visual self-report and electronic tracking of sensory pain [77e79,102]. Patients can choose from alibrary of pain quality ‘icons’ to express different types of pain, such as a ‘matchstick’ for ‘burning pain’.Descriptive icons can be assigned a rating of intensity (0e10 NRS) and then dragged-and-dropped ontoa detailed virtual body map to show pain location. All pain parameters are electronically captured and

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 325

can be used to track changes in pain over time. Studies to date in adolescents aged 12e18 years withchronic pain, including arthritis, indicate that Pain-QuILT™ is easy to use and understand, preferred byamajority of patients, and perceived to improve the communication of pain symptomswith healthcareproviders. A free version of the tool is available at: http://painquilt.mcmaster.ca.

Section summary

� Information and communication technologies offer great opportunities for innovation in the field ofpain assessment by capturing:

B real time data of pain ‘right now’ without memory bias,

B longitudinal pain reports that account for the dynamic fluctuations in arthritis pain.

Strategies for clinical management of pain

The consideration of pain within the biopsychosocial model means that clinicians should usemultimodal approaches for the management of pain. This section will provide a brief overview ofcurrently recommended pain management strategies, including pharmacological, physical, and psy-chological approaches.

Pharmacological treatment of pain

To date, there have been no clinical trials that directly address pain management in JIA [18]. Thestandard approach for treating active arthritis often includes non-steroidal anti-inflammatories(NSAIDs) such as naproxen, disease-modifying anti-rheumatic drugs such as methotrexate, and bio-logical therapies such as anti-tumour necrosis factor-alpha agents [80e83]. Additionally, acute diseaseflares may be treated with short-course systemic corticosteroids and/or intra-articular corticosteroidinjections [84]. Many of these pharmacological therapies result in improved pain and HRQL. Clinicalstudies have demonstrated that many pharmacological therapies for JIA are associated with reducedpain and improved function. For example, in a study involving 521 patients with polyarticular JIA,C�espedes-Cruz et al. report that treatment with methotrexate over a six-month period was associatedwith significant improvements across all HRQL areas, particularly in physical domains [85]. In addi-tion, the total number of painful joints and parents' scores of child pain intensity (measured on a0e10 cm VAS) was significantly reduced from baseline to six-months [85]. Similarly, Prince andcolleagues followed a cohort of 53 patients with refractory JIA over a 27-month period of treatmentwith etanercept [86]. These investigators assessed HRQL and pain at baseline and after 3 months, 15months, and 27 months of treatment. There were significant improvements observed in HRQL andpain after 3 months of etanercept treatment, and these improvements were sustained over the studyperiod.

In addition to pharmacological therapies that aim to reduce arthritis disease activity, acute painflares can be treated with NSAIDs such as naproxen [87]. The combination of acetaminophen andnaproxen can also be used for the effective treatment of mild pain [18,21]. For patients with moresevere pain, the use of opioids can be considered [88]. The recent Canadian best practice guidelines forthe treatment of chronic pain include recommendations regarding use of opioids [89]. However, thereis limited research on the use of opioids in children and adolescents with arthritis. According to asurvey of North American pediatric rheumatologists, only 51% of respondents indicated that they werecomfortable in prescribing opioids and other potent analgesics to their patients [3]. However, assummarized by Kimura and colleagues, “… chronic opioid use to achieve pain control may be pref-erable to escalating therapy with potentially dangerous treatments such as DMARDs, steroids, andbiologic response modifiers, especially when the opioids are prescribed based on a protocol structuredto highlight safety and proper use” (p. 82) [3]. Lastly, consultation with a specialized pediatric chronicpain team should be considered for patients with refractory pain.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330326

Physical strategies for treatment of pain

Many patients who are under treatment with pharmacological therapy still continue to experiencesignificant pain [1,21]. In addition, a recent systematic review demonstrated that patients with JIA havemoderate to severe impairment in physical fitness compared to healthy children [90]. Thus, it isimportant for clinicians to incorporate physical strategies into their management plan.

Participation in regular physical activity has been shown to improve symptoms of pain, fatigue, anddisability over the long term for children and adolescents with arthritis. One of the biggest challengesassociated with physical therapies is that an increase in exercise can initially exacerbate pain [91].However, participation in a sustained exercise routine is associated with benefits such as improvedstrength and general health. There is also a growing body of research suggesting that regular physicalactivity can reduce pain. For example, Klepper and colleagues evaluated the effects of an 8-weekweight-bearing physical condition program in 25 patients with JIA. Significant improvements were found inphysical fitness, and mean pain intensity scores decreased 16% from baseline to study end [92]. In arandomized controlled trial involving 80 patients with JIA, Singh-Grewal et al. compared vigorous andgentle exercise regimens over an 8-week period [93]. These investigators found that both exercise reg-imens were well tolerated and led to improvements in physical function. However, while a Cochranemeta-analysis of existing randomized controlled trials found that exercise does not exacerbate arthritis,this analysis also failed to identify significant evidence of improvements in pain [94]. The Canadian Pe-diatric Society currently recommends that children with JIA should take part in moderate fitness, flexi-bility, and strengthening exercises [95]. However, as summarized by Tupper, “patients must continuallystrive for a level of exercise that stresses their systems sufficiently to improve function yet avoid a levelthat causesanexcessive symptomreaction, signaling that thepatient has exceededa safe limit” (p. 7) [91].

Psychological strategies for treatment of pain

Studies in pediatric chronic illnesses have shown that comprehensive psycho-educational in-terventions are associated with symptom reduction and improved HRQL compared with care that isstrictlymedication focused, with a postulatedmechanism of enhanced self-efficacy and empowermentover disease and symptom management [96,97]. Self-efficacy has been defined as the patient'sperceived ability to successfully produce a desired effect in a task or behaviour affecting their life [98].

Some of the most successful psychological strategies for improving pain and associated functionalimpairments are rooted in cognitive-behavioural therapy (CBT) [99]. CBT typically incorporatesnormalization of the patient's experience through education, training in strategies for managingdisease-related symptoms and other stressors, enhancing self-efficacy, and guidance on developingand implementing a long-term management plan [100,101]. A systematic review of 25 randomizedcontrolled trials involving 1247 children and adolescents with chronic pain found that omnibus CBT,relaxation therapy, and biofeedback all produced significant positive effects on pain reduction [101].

Given the strong empirical foundation for psychological interventions in improving the coping skillsnecessary for reducing pain and improving HRQL in chronic pain, it is recommended that thesetherapies be considered for children and adolescents with persistent arthritis pain [100,101].

Section summary

- No clinical trials to date have directly addressed pain management in JIA.- Pharmacological treatment is typically focused on controlling underlying disease activity withNSAIDs, disease-modifying anti-rheumatic drugs, and biological therapies.

- Acute pain flares can be managed with agents such as NSAIDs and acetaminophen, while for severepain, opioids can be considered.

- Many patients continue to experience arthritis pain despite adequate pharmacological treatment.- Physical therapies are a vital component of improving disease management, including pain andfunction. Clinicians should aim to help patients achieve an optimal level of physical activity in orderto improve function within safe limits.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 327

- Psychological therapies, in particular cognitive-behavioural therapy, are an important part of painmanagement and have demonstrated efficacy in improving pain and HRQL.

Chapter summary

It is critically important for clinicians to recognize that pain is the most common and distressingsymptom of JIA. Therefore, the frequent and consistent assessment of pain using valid, reliable, andage-appropriate tools should form a cornerstone of disease management. Given that many patientswill continue to experience pain despite adequate pharmacological treatment, clinicians shouldincorporate other painmanagementmodalities, such as physical and psychological therapies, into theirpractice.

While there has been great progress in the field, unanswered questions still remain and must beaddressed in future research. Despite recent advances in pharmacotherapy, children and adolescentswith arthritis continue to experience significant persistent pain. Thus, there is an urgent need to betterunderstand the neurobiological pain processing mechanisms in the central nervous system that persistfollowing the resolution of the inflammatory component of JIA. It is likely that current therapies do notaddress or target these changes. However, to date, there have been no clinical trials to directly evaluatethe effectiveness of different pain medications for alleviating pain in JIA. In the context of the bio-psychosocial model, future work is also needed to better understand the impact of factors such asmood, anxiety, and pain coping in the maintenance of JIA pain.

Practice points

� Pain is a common and distressing component of arthritis.

� Pain should be assessed frequently and consistently throughout the disease management

process using valid and reliable tools.

� Pain management strategies, including pharmacological, physical, and psychological ap-

proaches, are an essential part of overall disease management.

Research agenda

� Information and communication technologies (e.g. Internet, smartphones) are a promising

means of improving pain assessment. Further research is needed to rigorously evaluate

these electronic tools and determine feasibility of incorporation into routine clinical practice.

� There is a need for clinical trials to evaluate different pain management strategies for JIA.

References

[1] Schanberg LE, Anthony KK, Gil KM, et al. Daily pain and symptoms in children with polyarticular arthritis. Arthritisand Rheumatism 2003;48:1390e7.

[2] Stinson JN, Stevens BJ, Feldman BM, et al. Construct validity of a multidimensional electronic pain diary for adoles-cents with arthritis. Pain 2008;136:281e92.

*[3] Kimura Y, Walco GA, Sugarman E, et al. Treatment of pain in juvenile idiopathic arthritis: a survey of pediatricrheumatologists. Arthritis and Rheumatism 2006;55:81e5.

*[4] Bromberg MH, Connelly M, Anthony KK, et al. Self-reported pain and disease symptoms persist in juvenile idiopathicarthritis despite treatment advances: an electronic diary study. Arthritis & Rheumatology 2014;66:462e9.

[5] Hogeweg JA, Kuis W, Huygen AC, et al. The pain threshold in juvenile chronic arthritis. British Journal of Rheuma-tology 1995;34:61e7.

[6] Thastum M, Zachariae R, Herlin T. Pain experience and pain coping strategies in children with juvenile idiopathicarthritis. The Journal of Rheumatology 2001;28:1091e8.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330328

[7] Leegaard A, Lomholt JJ, Thastum M, et al. Decreased pain threshold in juvenile idiopathic arthritis: a cross-sectionalstudy. The Journal of Rheumatology 2013;40:1212e7.

*[8] Munro J, Singh-Grewal D. Juvenile idiopathic arthritis and pain e more than simple nociception. The Journal ofRheumatology 2013;40:1037e9.

[9] Sawyer MG, Whitham JN, Roberton DM, et al. The relationship between health-related quality of life, pain and copingstrategies in juvenile idiopathic arthritis. Rheumatology (Oxford, England) 2004;43:325e30.

[10] Shaw KL, Southwood TR, Duffy CM, et al. Health-related quality of life in adolescents with juvenile idiopathic arthritis.Arthritis and Rheumatism 2006;55:199e207.

[11] Butbul Aviel Y, Stremler R, Benseler SM, et al. Sleep and fatigue and the relationship to pain, disease activity andquality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology 2011;50:2051e60.

[12] Valrie CR, Bromberg MH, Palermo T, et al. A systematic review of sleep in pediatric pain populations. Journal ofDevelopmental and Behavioral Pediatrics 2013;34:120e8.

*[13] Tong A, Jones J, Craig JC, et al. Children's experiences of living with juvenile idiopathic arthritis: a thematic synthesis ofqualitative studies. Arthritis Care & Research 2012;64:1392e404.

*[14] Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome.Rheumatology (Oxford, England) 2002;41:1428e35.

[15] Tupper SM, Rosenberg AM, Pahwa P, et al. Pain intensity variability and its relationship with quality of life in youthswith juvenile idiopathic arthritis. Arthritis Care & Research 2013;65:563e70.

[16] Clinch J, Eccleston C. Chronic musculoskeletal pain in children: assessment and management. Rheumatology 2009;48:466e74.

[17] Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277e99.[18] Anthony KK, Schanberg LE. Pediatric pain syndromes and management of pain in children and adolescents with

rheumatic disease. Pediatric Clinics of North America 2005;52:611e639-vii.[19] Malleson PN, Oen K, Cabral DA, et al. Predictors of pain in children with established juvenile rheumatoid arthritis.

Arthritis and Rheumatism 2004;51:222e7.[20] Schanberg LE, Lefebvre JC, Keefe FJ, et al. Pain coping and the pain experience in children with juvenile chronic

arthritis. Pain 1997;73:181e9.[21] Kimura Y, Walco GA. Treatment of chronic pain in pediatric rheumatic disease. Nature Clinical Practice Rheumatology

2007;3:210e8.[22] Johnston C. Psychometric issues in the measurement of pain. In: Finley GA, McGrath PJ, editors. Measurement of pain

in infants and children, progress in pain research management, vol. 10. Seattle: IASP Press; 1998. pp. 5e20.*[23] Lovell DJ, Passo MH, Beukelman T, et al. Measuring process of arthritis care: a proposed set of quality measures for the

process of care in juvenile idiopathic arthritis. Arthritis Care & Research 2011;63:10e6.[24] von Baeyer CL, Uman LS, Chambers CT, et al. Can we screen young children for their ability to provide accurate self-

reports of pain? Pain 2011;152:1327e33.[25] von Baeyer CL. Children's self-reports of pain intensity: scale selection, limitations and interpretation. Pain Research

and Management 2006;11:157e62.*[26] von Baeyer CL, Spagrud LJ. Systematic review of observational (behavioral) measures of pain for children and ado-

lescents aged 3 to 18 years. Pain 2007;127:140e50.[27] Craig K. The facial display of pain. In: Finley G, McGrath P, editors. Measurement of pain in infants and children.

Seattle: IASP Press; 1998. pp. 103e21.[28] McGrath P. Behavioral measures of pain. In: Finley G, McGrath P, editors. Measurement of pain in infants and children.

Seattle: IASP Press; 1998. pp. 83e101.[29] Craig KD, Badali MA. Introduction to the special series on pain deception and malingering. The Clinical Journal of Pain

2004;20:377e82.[30] Breau LM, McGrath PJ, Camfield CS, et al. Psychometric properties of the non-communicating children's pain

checklist-revised. Pain; 2002.[31] Breau LM, Camfield C, McGrath PJ, et al. Measuring pain accurately in children with cognitive impairments: refine-

ment of a caregiver scale. The Journal of Pediatrics 2001;138:721e7.[32] Breau LM, Finley GA, McGrath PJ, et al. Validation of the non-communicating Children's pain checklist-postoperative

version. Anesthesiology 2002;96:528e35.[33] Merkel SI, Voepel-Lewis T, Shayevitz JR, et al. The FLACC: a behavioral scale for scoring postoperative pain in young

children. Pediatric Nursing 1997;23:293e7.[34] Malviya S, Voepel-Lewis T, Burke C, et al. The revised FLACC observational pain tool: improved reliability and validity

for pain assessment in children with cognitive impairment. Paediatric Anaesthesia 2006;16:258e65.[35] Hester N, Foster R, Jordan-Marsh M, et al. Putting pain measurement into clinical practice. In: Finley G, McGrath P,

editors. Measurement of pain in infants and children. Seattle: IASP Press; 1998. pp. 179e98.[36] McCaffery M, Pasero C. In: Pain: clinical manual. 2nd ed. St Louis: Mosby; 1999.[37] Goodenough B, Addicoat L, Champion GD, et al. Pain in 4- to 6-year-old children receiving intramuscular injections: a

comparison of the faces pain scale with other self-report and behavioral measures. The Clinical Journal of Pain 1997;13:60e73.

[38] Ruskin D, Lalloo C, Amaria K, et al. Assessing pain intensity for children with chronic pain: convergent anddiscriminant validity of the 0e10 numerical rating scale in clinical practice. Pain Research and Management 2014;19:141e8.

[39] von Baeyer CL, Spagrud LJ, McCormick JC, et al. Three new datasets supporting use of the numerical rating scale (NRS-11) for children's self-reports of pain intensity. Pain 2009;143:223e7.

[40] Mir�o J, Castarlenas E, Huguet A. Evidence for the use of a numerical rating scale to assess the intensity of pediatricpain. European Journal of Pain 2009;13:1089e95.

[41] Bailey B, Daoust R, Doyon-Trottier E, et al. Validation and properties of the verbal numeric scale in children with acutepain. Pain 2010;149:216e21.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330 329

[42] Voepel-Lewis T, Burke C, Jeffreys N, et al. Do 0e10 numeric rating scores translate into clinically meaningful painmeasures for children? Anesthesia & Analgesia 2011;112:415e21.

[43] Tomlinson D, von Baeyer CL, Stinson JN, et al. A systematic review of faces scales for the self-report of pain intensity inchildren. Pediatrics 2010;126:e1168e98.

[44] Chambers CT, Craig KD. An intrusive impact of anchors in children's faces pain scales. Pain; 1998.[45] Beyer JE, Denyes MJ, Villarruel AM. The creation, validation, and continuing development of the Oucher: a measure of

pain intensity in children. Journal of Pediatric Nursing 1992;7:335e46.[46] Hicks CL, von Baeyer CL, Spafford PA, et al. The faces pain scale-revised: toward a common metric in pediatric pain

measurement. Pain 2001;93:173e83.[47] Wong D, Baker C. Pain in children: comparison of assessment scales. Pediatric Nursing 1988;14:9e17.[48] da Silva FC, Santos Thuler LC, de Leon-Casasola OA. Validity and reliability of two pain assessment tools in Brazilian

children and adolescents. Journal of Clinical Nursing 2011;20:1842e8.*[49] Stinson JN, Kavanagh T, Yamada J, et al. Systematic review of the psychometric properties, interpretability and

feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 2006;125:143e57.

[50] McGrath PA, Seifert CE, Speechley KN, et al. A new analogue scale for assessing children's pain: an initial validationstudy. Pain 1996;64:435e43.

[51] Bulloch B, Garcia-Filion P, Notricia D, et al. Reliability of the color analog scale: repeatability of scores in traumatic andnontraumatic injuries. Academic Emergency Medicine 2009;16:465e9.

[52] Bulloch B, Tenenbein M. Validation of 2 pain scales for use in the pediatric emergency department. Pediatrics 2002;110:e33.

[53] Hester NK. The preoperational child's reaction to immunization. Nursing Research 1979;28:250e5.[54] Gharaibeh M, Abu-Saad H. Cultural validation of pediatric pain assessment tools: Jordanian perspective. Journal of

Transcultural Nursing 2002;13:12e8.[55] Suraseranivongse S, Montapaneewat T, Manon J, et al. Cross-validation of a self-report scale for postoperative pain in

school-aged children. Journal of the Medical Association of Thailand 2005;88:412e8.[56] Varni JW, Thompson KL, Hanson V. The Varni/Thompson pediatric pain questionnaire. I. Chronic musculoskeletal pain

in juvenile rheumatoid arthritis. Pain 1987;28:27e38.[57] Abu-Saad HH. On the development of a multidimensional Dutch pain assessment tool for children. Pain 1990;43:

249e56.[58] Abu-Saad HH, Pool H, Tulkens B. Further validity testing of the Abu-Saad paediatric pain assessment tool. Journal of

Advance Nursing 1994;19:1063e71.[59] Savedra MC, Holzemer WL, Tesler MD, et al. Assessment of postoperation pain in children and adolescents using the

adolescent pediatric pain tool. Nursing Research 1993;42:5e9.[60] Crandall M, Savedra M. Multidimensional assessment using the adolescent pediatric pain tool: a case report. Journal of

Specialists in Pediatric Nursing 2005;10:115e23.[61] Jacob E, Mack AK, Savedra M, et al. Adolescent pediatric pain tool for multidimensional measurement of pain in

children and adolescents. Pain Management Nursing; 2013.*[62] von Baeyer CL. Children's self-report of pain intensity: what we know, where we are headed. Pain Research and

Management 2009;14:39e45.[63] Connelly M, von Baeyer CL, Stinson JN, et al. Pain as a quality of care measure in juvenile idiopathic arthritis: one step

forward, but is it the best foot? Comment on the article by Lovell, et al. Arthritis Care and Research 2011;63:1352e3.[64] Stinson JN. Improving the assessment of pediatric chronic pain: harnessing the potential of electronic diaries. Pain

Research and Management 2009;14:59e64.[65] Gendreau M, Hufford MR, Stone AA. Measuring clinical pain in chronic widespread pain: selected methodological

issues. Best Practice & Research Clinical Rheumatology 2003;17:575e92.[66] Gorin AA, Stone AA. Recall biases and cognitive errors in retrospective self-reports: a call for momentary assessments.

In: Baum ART, Singer J, editors. Handbook of health psychology. New Jersey: Erlbaum; 2001. pp. 405e13.[67] van den Brink M, Bandell-Hoekstra EN, A-S HH. The occurrence of recall bias in pediatric headache: a comparison of

questionnaire and diary data. Headache 2001;41:11e20.[68] Stone AA, Broderick JE. Real-time data collection for pain: appraisal and current status. Pain Medicine 2007;8:S85e93.[69] Stone AA, Schwartz JE, Broderick JE, et al. Variability of momentary pain predicts recall of weekly pain: a consequence

of the peak (or salience) memory heuristic. Personality and Social Psychology Bulletin 2005;31:1340e6.[70] Richardson GM, McGrath PJ, Cunningham SJ, Humphrey P. Validity of the headache diary for children. Headache 1983;

23:184e7.[71] Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Controlled Clinical Trials

2003;24:182e99.[72] Morren M, Dulmen SV, Ouwerkerk J, et al. Compliance with momentary pain measurement using electronic diaries: a

systematic review. European Journal of Pain 2008;13:354e65.[73] Palermo TM, Valenzuela D, Stork PP. A randomized trial of electronic versus paper pain diaries in children: impact on

compliance, accuracy, and acceptability. Pain 2004;107:213e9.[74] Stinson JN, Petroz GC, Tait G, et al. e-Ouch: usability testing of an electronic chronic pain diary for adolescents with

arthritis. The Clinical Journal of Pain 2006;22:295e305.[75] Stinson JN, Petroz GC, Stevens BJ, et al. Working out the kinks: testing the feasibility of an electronic pain diary for

adolescents with arthritis. Pain Research & Management 2008;13:375e82.[76] Stinson JN, Connelly M, Jibb LA, et al. Developing a standardized approach to the assessment of pain in children and

youth presenting to pediatric rheumatology providers: a Delphi survey and consensus conference process followed byfeasibility testing. Pediatric Rheumatology 2012;10:7e17.

[77] Lalloo C, Henry JL. Evaluation of the iconic pain assessment tool by a heterogeneous group of people in pain. PainResearch & Management 2011;16:13e8.

C. Lalloo, J.N. Stinson / Best Practice & Research Clinical Rheumatology 28 (2014) 315e330330

[78] Lalloo C, Stinson JN, Hochman JR, et al. Adapting the iconic pain assessment tool version 2 (IPAT2) for adults andadolescents with arthritis pain through usability testing and refinement of pain quality icons. The Clinical Journal ofPain 2013;29:253e64.

[79] Lalloo C, Stinson JN, Brown SC, et al. Pain-QuILT: assessing clinical feasibilty of a web-based tool for the visual self-report of pain in an interdisciplinary pediatric chronic pain clinic. The Clinical Journal of Pain; 1e10, in press.

[80] Takken T, Van Der Net J. Methotrexate for treating juvenile idiopathic arthritis. Cochrane Database Systematic Reviews2001;4.

[81] Lovell DJ, Giannini EH, Reiff A. Etanercept in children with polyarticular juvenile rheumatoid arthritis. New EnglandJournal of Medicine 2000;342:763e9.

[82] Ruperto N, Lovell DJ, Cuttica R, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for thetreatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis and Rheumatism 2007;56:3096e106.

[83] Lovell DJ, Ruperto N, Goodman S, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.New England Journal of Medicine 2008;359:810e20.

[84] Beukelman T, Guevara JP, Albert DA, et al. Usage of intra-articular corticosteroid injections for the treatment of ju-venile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada. Clinical andExperimental Rheumatology 2008;26:700e3.

[85] C�espedes-Cruz A, Guti�errez-Su�arez R, Pistorio A, et al. Methotrexate improves the health-related quality of life ofchildren with juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2008;67:309e14.

[86] Prince FHM, Geerdink LM, Borsboom GJJM, et al. Major improvements in health-related quality of life during the use ofetanercept in patients with previously refractory juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2010;69:138e42.

[87] Kvien TK, Høyeraal HM, Sandstad B. Naproxen and acetylsalicylic acid in the treatment of pauciarticular and poly-articular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blindparallel study. Scandinavian Journal of Rheumatology 1984;13:342e50.

[88] Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectivenessand side effects. CMAJ: Canadian Medical Association Journal 2006;174:1589e94.

[89] Furlan AD, Reardon R, Weppler C, et al. Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ:Canadian Medical Association Journal 2010;182:923e30.

[90] Takken T, Hemel A, van der Net J, et al. Aerobic fitness in children with juvenile idiopathic arthritis: a systematicreview. The Journal of Rheumatology 2002;29:2643e7.

[91] Tupper S. The paradox of physical activity and pain for childrenwith juvenile idiopathic arthritis. Pediatric Pain Letter;2008.

[92] Klepper SE. Effects of an eight-week physical conditioning program on disease signs and symptoms in children withchronic arthritis. Arthritis Care and Research 1999;12:52e60.

[93] Singh-Grewal D, Schneiderman-Walker J, Wright V, et al. The effects of vigorous exercise training on physical functionin children with arthritis: a randomized, controlled, single-blinded trial. Arthritis and Rheumatism 2007;57:1202e10.

[94] Takken T, Van Brussel M, Engelbert R, et al. Exercise therapy in juvenile idiopathic arthritis: a Cochrane Review.European Journal of Physical and Rehabilitation Medicine 2008;44:287e97.

[95] Philpott JF, Houghton K, Luke A. Physical activity recommendations for children with specific chronic health condi-tions: juvenile idiopathic arthritis, hemophilia, asthma, and cystic fibrosis. Clinical Journal of Sport Medicine 2010;20:167e72.

*[96] Palermo TM, Eccleston C, Lewandowski AS, et al. Randomized controlled trials of psychological therapies for man-agement of chronic pain in children and adolescents: an updated meta-analytic review. Pain 2010;148:387e97.

[97] Barlow JH, Ellard DR. The psychosocial well-being of children with chronic disease, their parents and siblings: anoverview of the research evidence base. Child Care, Health and Development 2006;32:19e31.

[98] Jensen MP, Turner JA, Romano JM. Self-efficacy and outcome expectancies: relationship to chronic pain copingstrategies and adjustment. Pain 1991;44:263e9.

[99] Jensen MP. A neuropsychological model of pain: research and clinical implications. Journal of Pain 2010;11:2e12.[100] Eccleston C, Williams A, Morley S. Psychological therapies for the management of chronic pain (excluding headache)

in adults. Cochrane Database of Systematic Reviews (Online); 2009:CD007407.[101] Palermo TM, Wilson AC, Peters M, et al. Randomized controlled trial of an Internet-delivered family cognitive-

behavioral therapy intervention for children and adolescents with chronic pain. Pain 2009;146:205e13.[102] Lalloo C, Kumbhare D, Stinson JN, Henry JL. Pain-QuILT: clinical feasibility of a web-cased visual pain assessment tool

in adults with chronic pain. Journal of Medical Internet Research 2014;16(5). e127.